Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer
Background Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by enhancing antitumor immunity, yet durable responses are observed in only a fraction of patients. Identifying accessible and reliable biomarkers to predict therapeutic efficacy remains a critical unmet need. D-dime...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2026-12-01
|
| Серія: | Annals of Medicine |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/07853890.2026.2620195 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|